BerGenBio — Director's Dealing 2022

Jan 10, 2022

K R T - 1 5 0 0 T e m pla t e f o r n o tific a tio n o f t r a n s a c tio n s b y p e r s o n s dis c h a r gin g m a n a g e rial r e s p o n sibilitie s ( PDM R ) a n d p e r s o n s clo s ely a s s o cia t e d wit h t h e m

The person liable:

• PDMR Closely associated person (natural person)
  -
• Closely associated person (legal person)

Info about the one who reports
Last name	SKEIE
First name	RUNE
Business name	BerGenBio A S A

About PDMR
Last name	Olin
First name	Martin
Position / role	CEO

Initial notification or amendment to prior notification
Initial	Amendment

Details about the issuer or emission allowance market participant
Business name	BerGenBio A S A
LEI number	213800TYYFXKYF3V2A23

Skjema versjon: 46345

K R T - 1 5 0 0 T e m pla t e f o r n o tific a tio n o f t r a n s a c tio n s b y p e r s o n s dis c h a r gin g m a n a g e rial r e s p o n sibilitie s ( PDM R ) a n d p e r s o n s clo s ely a s s o cia t e d wit h t h e m

1/10/2022 7:45:16 PM AR468062473

Description of the financial instrument/type of instrument
Instrument	Share
ISIN code	NO 001 0650013
Name of the financial instrument
Shares in BerGenBio A S A
Nature of the transaction
Transaction type	Acquisition
Share option program
The transaction is linked to an excersise of a share option program Yes No
Currency of the transaction
Currency	NOK
Price(s) and volume(s)
Price per unit	20.508
Volume	9 100
Aggregated information
Average price per unit	20.50800
Aggregated volume	9 100
Total amount	186 622.800000
Date of the transaction
Date	1/10/2022
Place of the transaction
Trading venue	XOSL - Oslo Børs
Comment